Sarah Er Halford (Sarah Halford)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Advanced Cancer

Respiratory Syndrome Coronavirus

Protein Protein

Top Venues

Exploration of targeted anti-tumor therapy

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Ali Jn Duabil, Christian R Cooper, Esraa Aldujaily, Sarah Er Halford, Sandra Hirschberg, Sidath D Katugampola, George D D Jones
Investigations of the novel checkpoint kinase 1 inhibitor SRA737 in non-small cell lung cancer and colorectal cancer cells of differing tumour protein 53 gene status. Exploration of targeted anti-tumor therapy 4 (5) (2023)
Sarah Er Halford, Gareth J Veal, Stephen R Wedge, Geoffrey S Payne, Chris M Bacon, Philip Sloan, Ilaria Dragoni, Kathrin Heinzmann, Sarah Potter, Becky M Salisbury, Maxime Chénard-Poirier, Alastair P Greystoke, Elizabeth C Howell, William A Innes, Karen Morris, Chris Plummer, Mihaela Rata, George Petrides, Hector C Keun, Udai Banerji, Ruth Plummer
A Phase I Dose-Escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sarah Er Halford, Gareth J Veal, Stephen R Wedge, Geoffrey S Payne, Chris M Bacon, Philip Sloan, Ilaria Dragoni, Kathrin Heinzmann, Sarah Potter, Becky M Salisbury, Maxime Chénard-Poirier, Alastair P Greystoke, Elizabeth C Howell, William A Innes, Karen Morris, Chris Plummer, Mihaela Rata, George Petrides, Hector C Keun, Udai Banerji, Ruth Plummer
A Phase I Dose-Escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ali Jn Duabil, Christian R Cooper, Esraa Aldujaily, Sarah Er Halford, Sandra Hirschberg, Sidath D Katugampola, George D D Jones
Investigations of the novel checkpoint kinase 1 inhibitor SRA737 in non-small cell lung cancer and colorectal cancer cells of differing tumour protein 53 gene status. Exploration of targeted anti-tumor therapy 4 (5) (2023)
Sarah Er Halford, Susan Wan, Ilaria Dragoni, Julie Silvester, Bobojon Nazarov, Daniel Anthony, Suzie Anthony, Emma Ladds, John Norrie, Kevin Dhaliwal, null null
SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion. Trials 22 (1) (2021)